About Mark Pacyna
Mark Pacyna is Reprieve Cardiovascular's chief executive officer and an Agitated Solutions director. Reprieve develops technology that helps manage and accelerate fluid removal for heart failure patients. Agitated Solutions develops tools to improve ultrasound imaging and support diagnosis across several clinical uses.
He joined Reprieve as CEO in May 2021 after 16 years at Medtronic. His final Medtronic post led its peripheral vascular business, after roles in strategy, corporate development and sales across its cardiovascular and spine groups. He holds a University of Minnesota B.S.B. in management information systems and a University of Michigan MBA. He also serves on Reprieve's board of directors.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Mark Pacyna in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Pacyna works with at each company, as listed on that company's latest Form D.